HIF1 alpha antibody - KO/KD, Comparison, Orthogonal, Overexpression Validated

Catalog number: GTX127309100
Brand: GeneTex
Packing: 100 ul
Other sizes: Other size available
Price: On Request
Expected delivery time: 10 days
Quantity:
GTX127309 ChIP assay Image
GTX127309 WB Image...
GTX127309 ICC/IF Image
GTX127309 WB Image...
GTX127309 ICC/IF Image
GTX127309 WB Image...
GTX127309 ICC/IF Image
GTX127309 WB Image...
GTX127309 IHC-P Image
GTX127309 WB Image...
GTX127309 WB Image
GTX127309 WB Image...
GTX127309 WB Image
GTX127309 WB Image...
GTX127309 IP Image
GTX127309 WB Image...
GTX127309 WB Image
GTX127309 WB Image...
GTX127309 WB Image
GTX127309 WB Image...

Product specifications for - HIF1 alpha antibody - KO/KD, Comparison, Orthogonal, Overexpression Validated

Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: ChIP Chromatin ImmunoPrecipitation; ImmunoCytoChemistry; ImmunoFluorescence; ImmunoHistoChemistry; ImmunoHistoChemistry Frozen; ImmunoHistoChemistry Parrafin; ImmunoPrecipitation; Western Blot
Host: Rabbit
Target: HIF1A
Target description: hypoxia inducible factor 1 subunit alpha
Clonality: Polyclonal
Isotype: IgG
Properties: 
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 0.37 mg/ml
Storage instructions: 2-¦C to 8-¦C, -20-¦C or -80-¦C
Scientific information: 
Scientific info: Hypoxia-inducible factor-1 (HIF1) is a transcription factor found in mammalian cells cultured under reduced oxygen tension that plays an essential role in cellular and systemic homeostatic responses to hypoxia. HIF1 is a heterodimer composed of an alpha subunit and a beta subunit. The beta subunit has been identified as the aryl hydrocarbon receptor nuclear translocator (ARNT). This gene encodes the alpha subunit of HIF-1. Overexpression of a natural antisense transcript (aHIF) of this gene has been shown to be associated with nonpapillary renal carcinomas. Two alternative transcripts encoding different isoforms have been identified. [provided by RefSeq]
Gene ID: 3091
Swiss prot ID: Q16665
Additional information: 
Synonyms: GTX_citation; GTX127309; ARNT interacting protein; ARNT-interacting protein; basic-helix-loop-helix-PAS protein MOP1; bHLHe78; class E basic helix-loop-helix protein 78; HIF1; HIF-1A; HIF-1alpha; HIF-1-alpha; HIF1-ALPHA; hypoxia inducible factor 1 alpha subunit; hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor); hypoxia-inducible factor 1 alpha isoform I.3; hypoxia-inducible factor 1-alpha; hypoxia-inducible factor1alpha; member of PAS protein 1; member of PAS superfamily 1; MOP1; PAS domain-containing protein 8; PASD8
ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling. Yan Q et al., 2017 Nov 1, Cancer Res Read more
A novel family of fluorescent hypoxia sensors reveal strong heterogeneity in tumor hypoxia at the cellular level. Erapaneedi R et al., 2016 Jan 4, EMBO J Read more
Acute intermittent hypoxia and rehabilitative training following cervical spinal injury alters neuronal hypoxia- and plasticity-associated protein expression. Hassan A et al., 2018, PLoS One Read more
Adenylate kinase hCINAP determines self-renewal of colorectal cancer stem cells by facilitating LDHA phosphorylation. Ji Y et al., 2017 May 18, Nat Commun Read more
Adverse early-life environment impairs postnatal lung development in mice. Lai PY et al., 2019 Sep 1, Physiol Genomics Read more
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma. Wang M et al., 2017, Theranostics Read more
An Adaptation System to Avoid Apoptosis via Autophagy Under Hypoxic Conditions in Pancreatic Cancer Cells. Owada S et al., 2017 Sep, Anticancer Res Read more
Antitumor Activity of the Chinese Medicine JC-001 Is Mediated by Immunomodulation in a Murine Model of Hepatocellular Carcinoma. Chuang MH et al., 2017 Dec, Integr Cancer Ther Read more
Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. Li S et al., 2017, PLoS One Read more
Autophagy-mediated adaptation of hepatocellular carcinoma cells to hypoxia-mimicking conditions constitutes an attractive therapeutic target. Owada S et al., 2018 Apr, Oncol Rep Read more